Join to view full profile
4812 S 109th East AveSte. 200Tulsa, OK 74146
Phone+1 918-236-4567
Fax+1 918-236-4578
Dr. Martin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alan Martin is a rheumatologist based in Tulsa, OK, who completed his medical education at the University of Oklahoma College of Medicine in 1989, followed by a residency in internal medicine and a fellowship in rheumatology at the same institution. He has experience treating conditions such as ankylosing spondylitis, osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and gout. Dr. Martin has authored publications in reputable journals like The Journal of Rheumatology and Annals of the Rheumatic Diseases, which have been cited multiple times. He has contributed to clinical research through a Phase IIB Dose Ranging Study for rheumatoid arthritis. His accolades include multiple CMS Meaningful Use Certifications and being named a Fellow of the American College of Rheumatology.
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Rheumatology, 1993 - 1995- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1989 - 1993
- University of Oklahoma College of MedicineClass of 1989
Certifications & Licensure
VA State Medical License Current
OK State Medical License 1990 - 2027
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSuite, Greenway Health, LLC, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification Greenway PrimeSUITE, Greenway Health, LLC, 2013-2015, 2017
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- 11 citationsNeutropenia During Tocilizumab Treatment Is Not Associated With Infection Risk in Systemic or Polyarticular-Course Juvenile Idiopathic ArthritisManuela Pardeo, Jianmei Wang, Nicolino Ruperto, Ekaterina Alexeeva, Vyacheslav Chasnyk
The Journal of Rheumatology. 2019-03-01 - 199 citationsEfficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trialHermine I. Brunner, Nicolino Ruperto, Zbigniew Zuber, C. Keane, Olivier Harari
Annals of the Rheumatic Diseases. 2015-06-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: